Scholarlink

Background <p>Androgen Deprivation Therapy (ADT) is often a component of treatment for localised and advanced prostate cancer but carries multiple potential side-effects. We evaluated the feasibility of a clinical pathway delivering comprehensive geriatric assessment (CGA) for older men receiving ADT for prostate cancer, and its utility in targeting patients with multiple other long-term conditions.</p> Methods <p>This retrospective service evaluation included consecutive new patients aged 65 + with prostate cancer of any stage, commencing ADT in a dedicated uro-oncology clinic in a 6-month period in 2021. The clinical referral pathway to a specialist geriatric oncology clinic for CGA was available for any of these patients who the nurses delivering the ADT initiation clinic considered would benefit. Patient characteristics were compared and for those referred to the pathway, outcome measures included feasibility, effectiveness in targeting medically complex patients, and clinical utility including ADT-specific assessments and other CGA interventions.</p> Results <p>Overall, 84 patients were seen in the ADT clinic during the evaluation period with a mean age of 73.4 years (SD 6.6). 45% were referred for CGA and of these, 100% received CGA. There were a greater number of patients with 4 + long-term conditions in the group referred for CGA (76.3%) vs. those who were not (34.8%). ADT toxicity screening (non-radiological) was performed in over 80% of the 38 patients referred for CGA, and DEXA scanning was completed in 55.3%. For the 38 patients who received CGA, 188 interventions unrelated to ADT were also implemented. Interventions were varied and tailored to a range of long-term conditions, which may not have been identified outside CGA.</p> Conclusions <p>This service evaluation confirms the feasibility and utility of CGA performed in a specialist geriatric oncology clinic for older men commencing ADT for prostate cancer. To fully explore the impact of CGA on clinical outcomes (cancer-related and otherwise) for older men starting ADT, prospective studies are needed.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Feasibility & clinical utility of Comprehensive Geriatric Assessment (CGA) and interventions in older adults with prostate cancer on Androgen Deprivation Therapy (ADT); a retrospective service evaluation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月11日

查看全文
  • K Balachandran,
  • S Lightbody,
  • M Brennan,
  • R Evans,
  • L Fleure,
  • D Harari,
  • C Welch,
  • D Josephs,
  • D Enting,
  • T Kalsi

摘要

Background

Androgen Deprivation Therapy (ADT) is often a component of treatment for localised and advanced prostate cancer but carries multiple potential side-effects. We evaluated the feasibility of a clinical pathway delivering comprehensive geriatric assessment (CGA) for older men receiving ADT for prostate cancer, and its utility in targeting patients with multiple other long-term conditions.

Methods

This retrospective service evaluation included consecutive new patients aged 65 + with prostate cancer of any stage, commencing ADT in a dedicated uro-oncology clinic in a 6-month period in 2021. The clinical referral pathway to a specialist geriatric oncology clinic for CGA was available for any of these patients who the nurses delivering the ADT initiation clinic considered would benefit. Patient characteristics were compared and for those referred to the pathway, outcome measures included feasibility, effectiveness in targeting medically complex patients, and clinical utility including ADT-specific assessments and other CGA interventions.

Results

Overall, 84 patients were seen in the ADT clinic during the evaluation period with a mean age of 73.4 years (SD 6.6). 45% were referred for CGA and of these, 100% received CGA. There were a greater number of patients with 4 + long-term conditions in the group referred for CGA (76.3%) vs. those who were not (34.8%). ADT toxicity screening (non-radiological) was performed in over 80% of the 38 patients referred for CGA, and DEXA scanning was completed in 55.3%. For the 38 patients who received CGA, 188 interventions unrelated to ADT were also implemented. Interventions were varied and tailored to a range of long-term conditions, which may not have been identified outside CGA.

Conclusions

This service evaluation confirms the feasibility and utility of CGA performed in a specialist geriatric oncology clinic for older men commencing ADT for prostate cancer. To fully explore the impact of CGA on clinical outcomes (cancer-related and otherwise) for older men starting ADT, prospective studies are needed.